Precision radiation aims to cure prostate cancer without Whole-Gland treatment

NCT ID NCT05616650

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 32 times

Summary

This study tests a new type of radiation (SBRT) that targets only the tumor in the prostate, not the whole gland. The goal is to cure early-stage prostate cancer while reducing side effects like incontinence and impotence. About 42 men with low- or intermediate-risk cancer that hasn't spread will receive two painless radiation sessions one week apart. They will be followed for two years with scans and blood tests to see if the cancer is gone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.